FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer

von Liu, Cassie, Barger, Carter J., Karpf, Adam R.
Veröffentlicht in Cancers (Basel) (2021)

Pan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in Cancer

von Barger, Carter J, Branick, Connor, Chee, Linda, Karpf, Adam R.
Veröffentlicht in Cancers (Basel) (2019)

Protein Kinase Cα (PKCα) Is Resistant to Long Term Desensitization/Down-regulation by Prolonged Diacylglycerol Stimulation

von Lum, Michelle A., Barger, Carter J., Hsu, Alice H., Leontieva, Olga V., Black, Adrian R., Black, Jennifer D.
Veröffentlicht in J Biol Chem (2016)

DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer

von Zhang, Wa, Barger, Carter J, Link, Petra A, Mhawech-Fauceglia, Paulette, Miller, Austin, Akers, Stacey N, Odunsi, Kunle, Karpf, Adam R
Veröffentlicht in Epigenetics (2015)

Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression

von Barger, Carter J., Zhang, Wa, Hillman, Joanna, Stablewski, Aimee B., Higgins, Michael J., Vanderhyden, Barbara C., Odunsi, Kunle, Karpf, Adam R.
Veröffentlicht in Oncotarget (2015)

Global DNA Hypomethylation in Epithelial Ovarian Cancer: Passive Demethylation and Association with Genomic Instability

von Zhang, Wa, Klinkebiel, David, Barger, Carter J., Pandey, Sanjit, Guda, Chittibabu, Miller, Austin, Akers, Stacey N., Odunsi, Kunle, Karpf, Adam R.
Veröffentlicht in Cancers (Basel) (2020)

PRAME expression and promoter hypomethylation in epithelial ovarian cancer

von Zhang, Wa, Barger, Carter J., Eng, Kevin H., Klinkebiel, David, Link, Petra A., Omilian, Angela, Bshara, Wiam, Odunsi, Kunle, Karpf, Adam R.
Veröffentlicht in Oncotarget (2016)

NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma

von Haque, Moinul, Li, Jing, Huang, Yung-Hsing, Almowaled, Meaad, Barger, Carter J., Karpf, Adam R., Wang, Peng, Chen, Will, Turner, Suzanne D., Lai, Raymond
Veröffentlicht in Cancers (Basel) (2019)

Co-regulation and function of FOXM1/RHNO1 bidirectional genes in cancer

von Barger, Carter J, Chee, Linda, Albahrani, Mustafa, Munoz-Trujillo, Catalina, Boghean, Lidia, Branick, Connor, Odunsi, Kunle, Drapkin, Ronny, Zou, Lee, Karpf, Adam R
Veröffentlicht in eLife (2021)

Expression of the POTE gene family in human ovarian cancer

von Barger, Carter J, Zhang, Wa, Sharma, Ashok, Chee, Linda, James, Smitha R., Kufel, Christina N., Miller, Austin, Meza, Jane, Drapkin, Ronny, Odunsi, Kunle, Klinkebiel, David, Karpf, Adam R.
Veröffentlicht in Sci Rep (2018)

CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax

von Kour, Smit, Rana, Sandeep, Contreras, Jacob I., King, Hannah M., Robb, Caroline M., Sonawane, Yogesh A., Bendjennat, Mourad, Crawford, Ayrianne J., Barger, Carter J., Kizhake, Smitha, Luo, Xu, Hollingsworth, Michael A., Natarajan, Amarnath
Veröffentlicht in Mol Pharmacol (2019)

BORIS expression in ovarian cancer precursor cells alters the CTCF cistrome and enhances invasiveness through GALNT14

von Hillman, Joanna C., Pugacheva, Elena M., Barger, Carter J., Sribenja, Sirinapa, Rosario, Spencer, Albahrani, Mustafa, Truskinovsky, Alexander M., Stablewski, Aimee, Liu, Song, Loukinov, Dmitri I., Zentner, Gabriel E., Lobanenkov, Victor V., Karpf, Adam R., Higgins, Michael J.
Veröffentlicht in Mol Cancer Res (2019)

Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy

von Robb, Caroline M., Kour, Smit, Contreras, Jacob I., Agarwal, Ekta, Barger, Carter J., Rana, Sandeep, Sonawane, Yogesh, Neilsen, Beth K., Taylor, Margaret, Kizhake, Smitha, Thakare, Rhishikesh N., Chowdhury, Sanjib, Wang, Jing, Black, Jennifer D., Hollingsworth, Michael A., Brattain, Michael G., Natarajan, Amarnath
Veröffentlicht in Oncotarget (2017)

Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy

von Robb, Caroline M., Kour, Smit, Contreras, Jacob I., Agarwal, Ekta, Barger, Carter J., Rana, Sandeep, Sonawane, Yogesh, Neilsen, Beth K., Taylor, Margaret, Kizhake, Smitha, Thakare, Rhishikesh N., Chowdhury, Sanjib, Wang, Jing, Black, Jennifer D., Hollingsworth, Michael A., Brattain, Michael G., Natarajan, Amarnath
Veröffentlicht in Oncotarget (2020)